# Advisor Review - GPT-5-mini

**Role:** Academic advisor checking for fatal errors
**Model:** openai/gpt-5-mini
**Paper:** paper.pdf
**Timestamp:** 2026-02-07T03:55:46.977874
**Route:** OpenRouter + LaTeX
**Tokens:** 26989 in / 1122 out
**Response SHA256:** 2f887812571c2eaf

---

I reviewed the draft for fatal errors in the four mandated categories (Data-Design Alignment, Regression Sanity, Completeness, Internal Consistency). I inspected every table and the key figures you reference in the text and appendix.

Findings: I found no fatal errors.

- Data-design alignment: Treatment timing (in-force dates) is consistently coded and never exceeds the referendum date (May 21, 2017). The paper explicitly documents in-force dates (2011–2017) and uses those dates throughout; Basel-Stadt (in force Jan 2017) is consistently excluded from RDD where appropriate and included in cross-sectional analysis with explicit caveats. RDD samples are restricted to municipalities with a relevant treated-control canton border (corrected distance-to-own-canton-border construction), and the paper reports the border-pairs used. Panel/DiDisc specifications use pre/post referendum dates appropriately and note when a canton (BS) cannot be used for cohort-specific inference.

- Regression sanity: Coefficients and standard errors in all tables are sensible for the outcomes (percentage vote shares). I did not find any impossibly large coefficients or standard errors (no SEs >1000, no SE >100× coefficient, no R² outside [0,1], no negative SEs, and no "NA"/"TBD" placeholders in reported results). Where inference is fragile (few treated cantons), the paper documents this and reports alternative inference methods (wild-cluster bootstrap, permutation tests, border-pair clustering) and their p-values.

- Completeness: Tables report sample sizes and standard errors. I did not find placeholder strings (NA, TODO, XXX) in the main tables. Figures and tables referenced in the text appear to exist in the appendix. Methods described (RDD, Donut, DiDisc, permutation inference) have corresponding results reported.

- Internal consistency: Numbers cited in text match the tables (e.g., same-language RDD = −5.9 pp with SE = 2.32; OLS treatment estimate attenuation after language controls). Treatment timing is consistently described and tabulated (Table of in-force dates). The distinction between corrected vs pre-correction sample construction is explained and used consistently (main results use corrected sample; some robustness/placebo exercises explicitly note the sample difference).

Because my role is to flag only fatal errors that would embarrass or waste the journal's time, and I found none that meet that threshold, my verdict is:

ADVISOR VERDICT: PASS